Clinical Advisory Board (CAB)

The Clinical Advisory Board (CAB) will organise a consensus meeting with WP2, WP3, WP5, and patient organisations to define inclusion and exclusion criteria for the new patient cohort (Major Depressive Disorder, MDD). Furthermore, it will review the Schizophrenia (SZ) and Alzheimer Disease (AD) inclusion and exclusion criteria from PRISM in light of the newly added digital technologies, provide support to PRISM 2 members concerning the “PRISM 2 – VALIDATE” study, and review and assess the results of the interim evaluation.

Prof. Dr. Martien Kas

Professor of Behavioural Neuroscience

Phone: +31 (0)50 363 238 1

Send E-Mail

Prof. Dr. Brenda Penninx

Professor of Psychiatric Epidemiology

Phone: +31 (0)20 788 567 4

Send E-Mail

Prof. Dr. Nic van der Wee

Psychiatrist

Send E-Mail

Prof. Dr. Yolande Pijnenburg

Professor of Neurology

Send E-Mail

Dr. Hugh Marston, F.R.S.B.

Senior Vice President & Head of Global CNS Disease Research

Send E-Mail

Dr. Gerard Dawson

CEO P1vital Ltd

Send E-Mail

Dr. Amy Beckenstrom

Senior Digital Health Scientist

Send E-Mail

Dr. Celso Arango

Consultant Psychiatrist & Head of Division

Send E-Mail

Dr. Stephanie Bauduin

Psychologist

Send E-Mail

Dr. José Luis Ayuso Mateos

Chief of Psychiatry

Send E-Mail

Dr. Javier-David Lopez-Morinigo

Consultant Psychiatrist

Send E-Mail

Dr. Alba Vieira Campos

Neurologist

Send E-Mail

Dr. Vikas Sharma

Global Head Medicine CNS

Send E-Mail

Dr. Thomas Tzschentke

Senior Translational Medicine & Clinical Biomarker Lead – CNS Diseases

Send E-Mail

Dr. Joachim Scholpp

Global Head Translational Medicine CNS

Send E-Mail

Ana Ortiz-Tallo

Psychologist

Send E-Mail

Oliver Schofield

Clinical Project Manager

Send E-Mail

The PRISM 2 project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 101034377. The JU receives support from the European Union’s Horizon 2020 research and innovation programme, EFPIA, and Cohen Veterans Bioscience (CVB). The website reflects only the authors' views and IMI JU, EFPIA, CVB, and the European Commission are not responsible for any use that may be made of the information it contains.

© PRISM 2 consortium 2024